145 related articles for article (PubMed ID: 27523974)
1. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Lymphoid Neoplasms.
Ho C; Kluk MJ
Surg Pathol Clin; 2016 Sep; 9(3):489-521. PubMed ID: 27523974
[TBL] [Abstract][Full Text] [Related]
2. LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
Navrkalova V; Plevova K; Hynst J; Pal K; Mareckova A; Reigl T; Jelinkova H; Vrzalova Z; Stranska K; Pavlova S; Panovska A; Janikova A; Doubek M; Kotaskova J; Pospisilova S
J Mol Diagn; 2021 Aug; 23(8):959-974. PubMed ID: 34082072
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic approaches for the diagnosis of clonality in lymphoid neoplasms.
Willman CL; Griffith BB; Whittaker M
Clin Lab Med; 1990 Mar; 10(1):119-49. PubMed ID: 2184975
[TBL] [Abstract][Full Text] [Related]
4. DNA microarrays in lymphoid malignancies.
Rosenwald A
Oncology (Williston Park); 2003 Dec; 17(12):1743-8; discussion 1750, 1755, 1758-9 passim. PubMed ID: 14723013
[TBL] [Abstract][Full Text] [Related]
5. Regulatory Factor X 7 and its Potential Link to Lymphoid Cancers.
Fischer BA; Chelbi ST; Guarda G
Trends Cancer; 2020 Jan; 6(1):6-9. PubMed ID: 31952782
[TBL] [Abstract][Full Text] [Related]
6. Lymphoid malignancies: many tumor types, many altered genes, many therapeutic challenges.
Dalla-Favera R
J Clin Invest; 2012 Oct; 122(10):3396-7. PubMed ID: 23023709
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes.
Burnett RC; Vernau W; Modiano JF; Olver CS; Moore PF; Avery AC
Vet Pathol; 2003 Jan; 40(1):32-41. PubMed ID: 12627711
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Salivary Gland Tumors.
Seethala RR; Griffith CC
Surg Pathol Clin; 2016 Sep; 9(3):339-52. PubMed ID: 27523965
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic molecular pathology of lymphoid malignancies.
Fend F; van den Brand M; Groenen PJ; Quintanilla-Martinez L; Bagg A
Virchows Arch; 2024 Feb; 484(2):195-214. PubMed ID: 37747559
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
Kuo FC
Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic, Prognostic, and Predictive Role of Next-Generation Sequencing in Mature Lymphoid Neoplasms.
Slack GW
Surg Pathol Clin; 2023 Jun; 16(2):433-442. PubMed ID: 37149368
[TBL] [Abstract][Full Text] [Related]
12. [Lymphoid tissue neoplasms: lympholeukemia and (or) lymphoma].
Morozova VT
Klin Lab Diagn; 2002 Mar; (3):43-50. PubMed ID: 11980146
[No Abstract] [Full Text] [Related]
13. B- and T-cell gene rearrangement test: an overview of application and methodology.
Schultz DL; Farkas DH
Clin Lab Sci; 1993; 6(5):291-4. PubMed ID: 10146555
[TBL] [Abstract][Full Text] [Related]
14. Expression of activation-induced cytidine deaminase in malignant lymphomas infiltrating the bone marrow.
Engels K; Jungnickel B; Tobollik S; Hansmann ML; Kriener S; Willenbrock K
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):521-9. PubMed ID: 18776814
[TBL] [Abstract][Full Text] [Related]
15. Myeloid and lymphoid neoplasms with FGFR1 abnormalities: diagnostic and therapeutic challenges.
Savage NM; Johnson RC; Gotlib J; George TI
Am J Hematol; 2013 May; 88(5):427-30. PubMed ID: 22886804
[No Abstract] [Full Text] [Related]
16. [Overview of lymphoid neoplasms in the fourth edition of the WHO classification].
Tohda S
Rinsho Byori; 2012 Jun; 60(6):560-4. PubMed ID: 22880234
[TBL] [Abstract][Full Text] [Related]
17. [Molecular abnormalities in lymphomas].
Delsol G
Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
[TBL] [Abstract][Full Text] [Related]
18. Comparative cytogenetic and cytologic study in malignant lymphomas.
Răileanu-Motoiu I; Gociu M; Leahu S; Berceanu S
Med Interne; 1976; 14(2):115-20. PubMed ID: 1024250
[TBL] [Abstract][Full Text] [Related]
19. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Swerdlow SH; Campo E; Pileri SA; Harris NL; Stein H; Siebert R; Advani R; Ghielmini M; Salles GA; Zelenetz AD; Jaffe ES
Blood; 2016 May; 127(20):2375-90. PubMed ID: 26980727
[TBL] [Abstract][Full Text] [Related]
20. Molecular methods for detection of minimal residual disease following transplantation in lymphoid and plasma cell disorders.
Corradini P; Carniti C
Methods Mol Biol; 2014; 1109():209-37. PubMed ID: 24473786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
